First real world effectiveness study of Paxlovid and Molnupiravir: significant reduction in disease progression & all-cause mortality vs matched controls, more for Paxlovid, during Hong Kong BA.2 wave. Fast viral load reduction
https://twitter.com/EricTopol/status/1528026709341065217?s=20&t=U1hl24MaLLb0MZUGtWV2KA